E
RGEN icon

Ergoteles’s Repligen RGEN Stock Holding History

Ergoteles’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,947
Closed -$417K – 664
2023
Q2 		$417K Buy
2,947
+265
+10% +$42.5K 0.02% 683
2023
Q1 		$452K Buy
+2,682
New +$479K 0.02% 771
2022
Q1 		– Sell
-5,549
Closed -$1.47M – 1574
2021
Q4 		$1.47M Sell
5,549
-51,503
-90% -$13.9M 0.06% 327
2021
Q3 		$16.5M Buy
57,052
+55,495
+3,564% +$14.2M 0.6% 28
2021
Q2 		$311K Buy
+1,557
New +$302K 0.01% 1053
2021
Q1 		– Sell
-13,134
Closed -$2.52M – 1010
2020
Q4 		$2.52M Buy
+13,134
New +$2.39M 0.08% 230

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ergoteles's RGEN Position: Q3 2023 in Review

Ergoteles sold out of Repligen (RGEN) in Q3 2023, closing a stake of 2,947 shares — an estimated $417K sold.

Ergoteles first reported a position in RGEN in Q4 2020 and held it in 6 quarters. The position peaked at $16.5M in Q3 2021. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Ergoteles reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 2,947 Repligen shares in Q3 2023, an estimated $417K.
  • Ergoteles first reported a position in Repligen in Q4 2020 and held it in 6 quarters.
  • Ergoteles's Repligen position peaked at $16.5M in Q3 2021.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.